Humana Inc. (NYSE:HUM) Receives $195.73 Average PT from Analysts
Shares of Humana Inc. (NYSE:HUM) have been assigned an average recommendation of “Buy” from the sixteen ratings firms that are currently covering the firm. Five equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $195.73.
A number of research firms have commented on HUM. Leerink Swann reaffirmed an “outperform” rating on shares of Humana in a research report on Tuesday, June 21st. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Argus reaffirmed a “hold” rating on shares of Humana in a research report on Tuesday, August 23rd. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a research report on Monday, August 8th. Finally, Wolfe Research initiated coverage on shares of Humana in a research report on Tuesday, June 28th. They set a “market perform” rating and a $244.00 price objective for the company.
Shares of Humana (NYSE:HUM) opened at 174.58 on Thursday. The firm’s 50-day moving average price is $177.08 and its 200-day moving average price is $176.74. The stock has a market cap of $26.02 billion, a P/E ratio of 26.82 and a beta of 0.91. Humana has a 52-week low of $150.00 and a 52-week high of $191.65.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The business earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. During the same quarter in the previous year, the firm posted $1.67 EPS. The firm’s revenue was up 2.0% on a year-over-year basis. Equities analysts predict that Humana will post $9.26 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.66%. The ex-dividend date is Tuesday, October 11th. Humana’s payout ratio is currently 18.18%.
A number of hedge funds have recently made changes to their positions in HUM. Renaissance Technologies LLC boosted its stake in shares of Humana by 246.3% in the first quarter. Renaissance Technologies LLC now owns 446,000 shares of the insurance provider’s stock valued at $81,596,000 after buying an additional 317,200 shares during the last quarter. Arrowgrass Capital Partners US LP boosted its stake in shares of Humana by 1.8% in the first quarter. Arrowgrass Capital Partners US LP now owns 2,878,848 shares of the insurance provider’s stock valued at $526,685,000 after buying an additional 51,267 shares in the last quarter. Orbis Allan Gray Ltd acquired a new stake in shares of Humana during the first quarter valued at about $38,209,000. Hermes Investment Management Ltd. boosted its stake in shares of Humana by 8.6% in the second quarter. Hermes Investment Management Ltd. now owns 208,145 shares of the insurance provider’s stock valued at $37,441,000 after buying an additional 16,500 shares in the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of Humana by 4.7% in the first quarter. Wellington Management Group LLP now owns 3,447 shares of the insurance provider’s stock valued at $631,000 after buying an additional 154 shares in the last quarter. Institutional investors and hedge funds own 93.37% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.